{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:22:25Z","timestamp":1790878945882,"version":"4.1.0"},"reference-count":34,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2008,3,16]],"date-time":"2008-03-16T00:00:00Z","timestamp":1205625600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[2008,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> In peritoneal dialysis (PD) residual renal function contributes to improved patient survival and quality of life. Glucose degradation products (GDP) generated by heat sterilization of PD fluids do not only impair the peritoneal membrane, but also appear in the systemic circulation with the potential for organ toxicity. Here we show that in a rat model of advanced renal failure, GDP affect the structure and function of the remnant kidney.<\/jats:p><jats:p><jats:bold>Materials and methods\u2002<\/jats:bold> Sprague\u2010Dawley rats were randomly assigned to a two stage subtotal nephrectomy (SNX) or sham operation and were left untreated for 3\u00a0weeks. The SNX\u00a0+\u00a0GDP group continuously received chemically defined GDP intravenously for 4\u00a0weeks; the SNX and the sham\u2010operated rats remained without GDP. The complete follow\u2010up for all groups was 7\u00a0weeks postoperatively.<\/jats:p><jats:p>We analysed renal damage using urinary albumin excretion as well as a semiquantitative score for glomerulosclerosis and tubulointerstitial damage, as well as for immunohistochemical analyses.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> The SNX\u00a0+\u00a0GDP rats developed significantly more albuminuria and showed a significantly higher score of glomerulosclerosis index (GSI) and tubulointerstitial damage index (TII) as compared to SNX or control rats. In the SNX\u00a0+\u00a0GDP group the expression of carboxymethyllysine and methylglyoxal was significantly higher in the tubulointerstitium and the glomeruli compared to the SNX rats. Caspase 3 staining and TUNEL assay were more pronounced in the tubulointerstitium and the glomeruli of the SNX\u00a0+\u00a0GDP group. In SNX\u00a0+\u00a0GDP animals, the expression of the slit diaphragm protein nephrin, was significantly lower compared to SNX or control animals.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> In summary, our data suggests that GDP can significantly advance chronic kidney disease and argues that PD solutions containing high GDP might deteriorate residual renal function in PD.<\/jats:p>","DOI":"10.1111\/j.1365-2362.2008.01945.x","type":"journal-article","created":{"date-parts":[[2008,3,16]],"date-time":"2008-03-16T23:46:22Z","timestamp":1205711182000},"page":"296-305","source":"Crossref","is-referenced-by-count":34,"title":["Renal toxicity mediated by glucose degradation products in a rat model of advanced renal failure"],"prefix":"10.1111","volume":"38","author":[{"given":"S.","family":"M\u00fcller\u2010Krebs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. P.","family":"Kihm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Zeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. L.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Deppisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Wieslander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Henle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Penndorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Reiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. P.","family":"Nawroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Zeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Schwenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,3,26]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V12102158"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00184.x"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00747.x"},{"key":"e_1_2_8_5_2","first-page":"476","article-title":"Diurest Study Group: Decline of residual renal function in peritoneal dialysis patients depends on uptake of carbonyl compounds from the peritoneal cavity: First data of a prospective clinical trial","volume":"14","author":"Haag\u2010Weber M","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_8_6_2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/089686089501500212","article-title":"In vitro biocompatibility of a heat\u2010sterilized, low\u2010toxic, and less acidic fluid for peritoneal dialysis","volume":"15","author":"Wieslander AP","year":"1995","journal-title":"Perit Dial Int"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1997.22"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005020155"},{"key":"e_1_2_8_9_2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/089686080302300412","article-title":"Mesothelial toxicity of peritoneal dialysis fluids is related primarily to glucose degradation products, not to glucose per se","volume":"23","author":"Witowski J","year":"2003","journal-title":"Perit Dial Int"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00705.x"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V75667"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199309000-00011"},{"key":"e_1_2_8_13_2","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/clinchem\/35.7.1371","article-title":"Microplate measurement of urinary albumin and creatinine","volume":"35","author":"Magnotti RA","year":"1989","journal-title":"Clin Chem"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1996.186"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/14.8.1968"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1991.175"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1984.147"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1994.215"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.183"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.ndt.a027447"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1998.00951.x"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.03.058"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.33.1.212"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfl711"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00041552-199907000-00014"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63909-0"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000065100.17349.CA"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-004-0102-8"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00528.x"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.8.2424"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M202634200"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00560.2006"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.20.9436"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1177\/089686080502500308"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfl393"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2362.2008.01945.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2362.2008.01945.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T06:06:30Z","timestamp":1697177190000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2362.2008.01945.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,26]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["10.1111\/j.1365-2362.2008.01945.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2362.2008.01945.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,26]]}}}